Her primary scientific interests are in Antigen, MHC class II, Major histocompatibility complex, Epitope and Antigen presentation. Andrea J. Sant has included themes like Antibody and Glycoprotein in her Antigen study. Andrea J. Sant works mostly in the field of MHC class II, limiting it down to topics relating to Cell biology and, in certain cases, Antigen processing.
The concepts of her Major histocompatibility complex study are interwoven with issues in Molecular biology and Peptide. The subject of her Epitope research is within the realm of Immunology. Her Immunology research includes elements of Cytotoxic T cell and Virology.
MHC class II, Immunology, Epitope, Virology and Major histocompatibility complex are her primary areas of study. Her MHC class II study integrates concerns from other disciplines, such as MHC class I, Antigen presentation, Peptide and Cell biology. Andrea J. Sant usually deals with Immunology and limits it to topics linked to Cytotoxic T cell and Acquired immune system and Secondary infection.
Her study in the field of Immunodominance also crosses realms of Pandemic. Major histocompatibility complex is a subfield of Antigen that she tackles. Her work carried out in the field of Antigen brings together such families of science as Monoclonal antibody and Function.
Her main research concerns Virology, Virus, Immunology, Vaccination and Epitope. She interconnects Antibody, Recombinant DNA and Antigen in the investigation of issues within Virology. The study incorporates disciplines such as Glycosylation and Glycoprotein in addition to Antigen.
Her research in Immunology intersects with topics in Cytotoxic T cell and Peptide. Her Immunodominance study in the realm of Epitope interacts with subjects such as Pandemic. The Antigen-presenting cell study combines topics in areas such as Antigen presentation, MHC class II and CD40.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Seth J. Zost;Kaela Parkhouse;Megan E. Gumina;Kangchon Kim.
Proceedings of the National Academy of Sciences of the United States of America (2017)
The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates Immunodominance
Christopher A. Lazarski;Christopher A. Lazarski;Francisco A. Chaves;Scott A. Jenks;Shenhong Wu.
Immunity (2005)
Revealing the role of CD4(+) T cells in viral immunity.
Andrea J. Sant;Andrew McMichael.
Journal of Experimental Medicine (2012)
The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.
Andrea J. Sant;Francisco A. Chaves;Scott A. Jenks;Katherine A. Richards.
Immunological Reviews (2005)
The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
C C Stebbins;G E Loss;C G Elias;A Chervonsky.
Journal of Experimental Medicine (1995)
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells
Shouxiong Huang;Susan Gilfillan;Sojung Kim;Bruce Thompson.
Journal of Experimental Medicine (2008)
Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.
John E Katz;Christopher Stebbins;Ettore Appella;Andrea J. Sant.
Journal of Experimental Medicine (1996)
Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus
Katherine A. Richards;David Topham;Francisco A. Chaves;Andrea J. Sant.
Journal of Immunology (2010)
MHC class II antigen processing: biology of invariant chain.
Andrea J. Sant;Jim Miller.
Current Opinion in Immunology (1994)
Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan.
A J Sant;S E Cullen;K S Giacoletto;B D Schwartz.
Journal of Experimental Medicine (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Rochester Medical Center
University of Rochester Medical Center
Medical University of South Carolina
National Institute of Allergy and Infectious Diseases
University of Chicago
University of Chicago
Icahn School of Medicine at Mount Sinai
St. Jude Children's Research Hospital
Icahn School of Medicine at Mount Sinai
University of Rochester
Pennsylvania State University
Sony (Japan)
University of Cambridge
Southeast University
IBM (United States)
Deakin University
University of the Aegean
University of Sydney
University of Florida
University of Louisville
University of Tromsø - The Arctic University of Norway
Universidade de Vigo
Icahn School of Medicine at Mount Sinai
Centers for Disease Control and Prevention
Columbia University in the City of New York
University of Miami